Navigation Links
Westaim announces 2008 year-end results
Date:2/18/2009

December 31 ------------------ ------------------- (thousands of dollars) 2008 2007 2008 2007 ------------------------------------------------------------------------- Operating Activities (Loss) income from continuing operations $ (1,224) $ 1,169 $ (1,735) $ (2,830) Items not affecting cash Gain on sale of capital assets - (75) - (8,722) Change in fair value of third party asset-backed commercial paper 856 1,067 1,706 4,048 Loss on sale of third party asset-backed commercial paper - 1,067 - 1,067 Depreciation and amortization 497 403 1,937 2,093 Stock-based compensation expense 276 667 1,027 2,469 Non-controlling interest 259 806 (804) (1,293) (Gain) loss on issuance and repurchase of shares of subsidiary (121) 14 (96) 134 Write-down of capital assets 215 - 215 1,203 Dilution gain - - (6,000) (4,525) Gain on sale of investments - (2,648) (534) (2,648) Accounts receivable 3 (4,407) 9,057 (7,190) Inventories 662 1,508 838 4,128 Other (553) 1,087 (90) (98) Accounts payable and accrued liabilities (2,435) (5,808) 270 1,131 ------------------------------------------------------------------------- Cash (used in) provided from continuing operations (1,5
'/>"/>
SOURCE Westaim Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. The Westaim Corporation update on status of short-term investments
2. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. Westaim announces 2007 third quarter results
4. Westaim reduces ABCP exposure
5. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
6. Westaim announces 2007 year-end results
7. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
8. Westaim announces 2008 first quarter results
9. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
10. Westaim announces 2008 second quarter results
11. Westaim announces sale of iFire Technology Ltd. assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Minn. (PRWEB) January 22, 2015 Blue Cross ... those Minnesotans who exemplify what it means to “Live Fearless.” ... chance for people to share their stories about how they ... or simply inspired others by living in the moment. By ...
(Date:1/22/2015)... 22, 2015 Thousand of GranuFlo lawsuits ... recalled its GranuFlo and NaturaLyte dialysis concentrates continue to ... U.S. District Court, District of Massachusetts, Bernstein Liebhard LLP ... Court has remanded a case filed by the state ...
(Date:1/22/2015)... 2015 A study recently published ... journal Medicine & Science in Sports & Exercise ... help reduce gastrointestinal (GI) problems associated with physical ... in the double-blind, placebo-controlled study took 10 grams ...
(Date:1/22/2015)... 22, 2015 Payday lending practices in ... and cause financial distress to the states that permit ... Howard University’s Center on Race and Wealth. , While ... activity, payday loans at the same time substantially depress ...
(Date:1/22/2015)... released a new blog post explaining the importance of keeping a ... of an auto insurance policy . , Clients who driver ... their vehicle insurance policies. The safety a vehicle offers from its ... of this, drivers should always carry a first aid kit in ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... TORONTO, ON. For the first time ever, an ... on the world,s tallest mountain, shedding some light on ... places on earth. , The team,s surprising findings shatter ... avalanches, falling ice and pulmonary oedema (lung problems) and ...
... AT&T Inc. (NYSE: T ),has announced a ... Program (LFL) to support disadvantaged children in Australia. ... the Smith Family. Founded,in 1922, The Smith Family is ... children to create a better future,through education. , ...
... opens DNA2.0 Ltd. in the United Kingdom and hires Michael Dyson ... ... (PRWEB) December 10, 2008 -- DNA2.0, the leading gene synthesis and ... operations with the creation of the United Kingdom-based DNA2.0 Ltd. Michael ...
... that,Cymbalta (duloxetine HCl) 60 mg to 120 mg once ... in patients who had previously responded to the,medication and ... as,those patients who experienced at least three depressive episodes ... .001). Results from the 52-,week maintenance phase of ...
... analysis shows , , WEDNESDAY, Dec. 10 (HealthDay News) -- ... the risk of fractures in women but not in ... and Actos (pioglitazone) are used to lower blood sugar ... suggested that the risk for heart failure, death and ...
... The United States could be faced with a national health ... boomer population ages and a growing number of older adults ... That is the position of a team of researchers from ... and supportive care for older patients at risk of or ...
Cached Medicine News:Health News:Team probes why climbers die on Mount Everest 2Health News:AT&T Supports the Smith Family's Learning For Life Program 2Health News:AT&T Supports the Smith Family's Learning For Life Program 3Health News:AT&T Supports the Smith Family's Learning For Life Program 4Health News:DNA2.0 Expands European Presence By Opening UK Office: Experienced Life Sciences Executive, Dr. Michael Dyson, to Lead European Operations 2Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 2Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 3Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 4Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 5Health News:Study Showed New Episodes of Depression Delayed in People Taking Cymbalta(R) 6Health News:2 Diabetes Drugs Double Fracture Risk in Women 2Health News:2 Diabetes Drugs Double Fracture Risk in Women 3Health News:Surge in older cancer survivors expected as baby boomers age 2Health News:Surge in older cancer survivors expected as baby boomers age 3
(Date:1/23/2015)... 2015  MedScope ( www.medscope.org ), the leading provider of ... Connected World magazine Connected World Award for ... can be used anywhere, anytime. The nomination was made ... In nominating MedScope, Landon Garner , Director of ...
(Date:1/23/2015)... Jan. 23, 2015  Pete Rose, baseball,s all-time hits leader, is ... pain reliever Myoflex, Ducere Pharma has announced. "Pete,s ... excited to have him on board with Myoflex," said Ducere ... a legendary player who is known across all generations. The ...
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
Breaking Medicine Technology:MedScope Nominated by RacoWireless for Prestigious 2015 Connected World Magazine Connected World Award 2Pete Rose bets on Myoflex to relieve aches and pains 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3
... Fla., May 9 Osteoarthritis is a,painful ... 50,million people in the United States. It ... joints. The novel investigational pain medication,tapentadol, a ... patients with joint-disease pain, compared to those ...
... in Patients Following Bunionectomy, TAMPA, Fla., May ... several days following removal of a,bunion, one of ... tapentadol provided significant relief for patients who had ... with tapentadol,also resulted in patients reporting fewer gastrointestinal ...
Cached Medicine Technology:Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 2New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 3New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 4New Data From Phase 3 Study Suggests Tapentadol Immediate Release Effective for Acute Pain From Common Foot Surgery 5
... Bulb Direct has been ... Internet since 1996, and we ... 100% satisfaction guarantee. Check out ... and see our discount light ...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
With the Symphony family of Pacemakers, Ela presents the most advanced technology on the market. Symphony, lighter than a passport, will take your patients further, offering fast follow-up, using new...
.90mm (20G) guillotine cutting probe with 1.4mm (17G) removable irrigation sleeve...
Medicine Products: